Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study
| Autor: | Ruggeri, E.M., Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Mazzotta, M., Schirripa, M., Panichi, V., Pessina, G., Signorelli, C., Chilelli, M.G., Primi, F., Natoni, F., Fazio, S., Silvestri, M.A. |
|---|---|
| Zdroj: | In ESMO Open February 2022 7(1) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|